Table 2

Number of Ki67-positive cells and co-labeling with DCX
Ki67 DCX
WT KO WT KO
mean ± SEM mean ± SEM mean ± SEM mean ± SEM
P35 Ki67 abs. 8247.4 ± 746.1 800.0 ± 82.3*** --- ± --- --- ± ---
% of Ki67+ --- ± --- --- ± --- 24.1 ± 2.3 9.2 ± 4.6
abs. co-lab. --- ± --- --- ± --- 1700.7 ± 92.6 81.2 ± 40.8***
P88 Ki67 abs. 4029.0 ± 159.0 147.0 ± 21.7*** --- ± --- --- ± ---
% of Ki67+ --- ± --- --- ± --- 27.5 ± 2.8 8.3 ± 8.3*
abs. co-lab. --- ± --- --- ± --- 1072.5 ± 209.5 20.6 ± 20.6***
P288 Ki67 abs. 1038.0 ± 260.8 72.0 ± 3.5*** --- ± --- --- ± ---
% of Ki67+ --- ± --- --- ± --- 23.8 ± 6.3 0 ± 0**
abs. co-lab. --- ± --- --- ± --- 365.6 ± 35.6 0 ± 0*

Two-way ANOVA followed by Holm-Sidak post hoc test (*p < 0.05, **p < 0.01, ***p < 0.001; cD2KO compared to WT); Abbreviations: abs. – absolute, abs. co-lab. – absolute number of cells co-labeled with Ki67.

Ansorg et al.

Ansorg et al. BMC Neuroscience 2012 13:46   doi:10.1186/1471-2202-13-46

Open Data